Because synaptotoxic tau in Alzheimer’s disease brain aqueous extracts prepared by homogenization is mostly of intracellular origin, it is important to assess the effect of i.c.v. administration of extracellular synaptotoxic tau on LTD. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.